All three benchmark US indexes closed lower on Friday after fluctuating throughout the session.
Summit Therapeutics plc (:SMMT) performed nicely this week, continuing its impressive near-term upward movement. The stock has moved north 7.09% over the past week of trading.
Looking further out, over the past twelve months, Summit Therapeutics plc’s stock was -10.42% and -15.65% over the last quarter and -8.88% for the past six months.
Over the past 50 days, Summit Therapeutics plc (:SMMT) stock was -37.31% off of the high and 20.11% removed from the low. Their 52-Week High and Low are noted here. -37.31% (High), 32.96%, (Low).
Summit Therapeutics plc (:SMMT) may have great momentum, but how has it been performing relative to the market? The stock’s price is $10.57 and their relative strength index (RSI) stands at 47.54. RSI is a technical oscillator that shows price strength by comparing upward and downward movements. It indicates oversold and overbought price levels for a stock.
Disclaimer: The views, opinions, and information expressed in this article are those of the authors and do not necessarily reflect the official policy or position of any company stakeholders, financial professionals, or analysts. Examples of analysis performed within this article are only examples. They should not be utilized to make stock portfolio or financial decisions as they are based only on limited and open source information. Assumptions made within the analysis are not reflective of the position of any analysts or financial professionals. This is not a recommendation to buy or sell Summit Therapeutics plc (:SMMT).